3 assistance programs for Botox patients · 2 open today
Two AbbVie programs cover Botox: one for commercial insurance, one for uninsured patients. The one foundation fund on file, HealthWell’s Migraine Fund, is closed to new applications (last checked June 14, 2026) and applies to chronic migraine only.
Select the patient's insurance to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links · verified June 14, 2026
Botox · Chronic migraine · Commercial insurance
Eligible patients may pay $0
Example · Botox · 155 units + 45 JW · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With BOTOX Savings Program (BOTOX Complete) | |
|---|---|---|
| Drug responsibility | $260.56 | $0.00 |
| Administration (64615) | $31.40 | $0.00 |
| Patient owes | $291.96 | $0.00 |
Estimated patient savings: $291.96
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Also available if this patient’s coverage falls short
Free myAbbVie Assist (Botox Patient Assistance) for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
| Task | ✓ |
|---|---|
| Find programs for this insurance type | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance: Eligible commercially insured patients may qualify for the BOTOX Savings Program (BOTOX Complete). Eligible patients pay $0 out of pocket for Botox and the injection procedure, up to $4,000 per year; the spasticity indications carry their own cap of up to $1,000 per treatment and $5,000 per year. The program is limited to 5 treatments across all indications in any 12-month period. It excludes Medicare, Medicaid, TRICARE, VA and other government insurance. View current program ↑
How the procedure copay works: A Botox visit produces two charges: a drug line (J0585) and a procedure line for the chemodenervation itself (64615 for chronic migraine, or the CPT matching the site treated). Each has its own patient share. The BOTOX Savings Program is unusual among manufacturer programs in that it covers Botox drug AND injection procedure copays, coinsurance and deductibles, not the drug alone. It does not cover a separate office-visit copay.
Medicare: Manufacturer copay assistance is not available to patients using Medicare to pay for Botox; the BOTOX Savings Program explicitly excludes Medicare, Medicaid, TRICARE, VA and other government plans. The federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. What exists instead is a Medigap policy that picks up the Part B coinsurance (see the cost page for the math), Medicaid dual eligibility where it applies, and myAbbVie Assist for patients who meet its income criteria. myAbbVie Assist covers the drug only, not the injection procedure. View current options ↑
Medicare and the Migraine Fund: a Medicare patient with chronic migraine has a foundation route in principle: HealthWell’s Migraine Fund, a $4,000/year copay grant for patients at or below 500% of the federal poverty level. It is currently closed to new applications and waitlisted, though. This page’s fund card updates automatically when it reopens. No other Botox indication has a fund on file.
Uninsured: myAbbVie Assist provides Botox at no cost to qualifying uninsured patients (limited or no coverage) who meet AbbVie’s income criteria. It ships the drug free to the practice; it does not cover the injection procedure or office-visit fees, so the practice still bills the patient for the chemodenervation charge, or writes it off. HealthWell’s Migraine Fund requires commercial, Medicare, Medicaid or TRICARE insurance, not uninsured status, so it does not apply here; myAbbVie Assist remains the only route on file for an uninsured patient. Check today’s status ↑
Why fund status matters: Manufacturer programs can change between: OPEN Accepting applications now · WAITLIST Not enrolling immediately · CLOSED Not accepting new applications. Every CareCost program card shows the status and the date it was verified.
Why the product name matters: Botox, Dysport, Xeomin, Myobloc and Daxxify treat overlapping conditions but are separate molecules under separate HCPCS codes, each with its own manufacturer and its own assistance program. Confirm the product actually prescribed and billed before applying to an AbbVie program.
Yes. The BOTOX Savings Program (BOTOX Complete) is AbbVie’s current commercial-insurance program. Eligible patients pay $0 out of pocket for Botox and the injection procedure, up to $4,000 a year (spasticity indications up to $1,000 per treatment and $5,000 a year), across up to 5 treatments in any 12-month period. Apply on BotoxSavingsProgram.com ↗ Calculate cost with the program →
Yes, and that is what sets it apart from most manufacturer copay programs: it covers the copay, coinsurance or deductible on both the Botox drug charge and the injection procedure charge (64615 for chronic migraine, and the equivalent chemodenervation code for other sites), up to the same annual maximum. It does not cover a separate office-visit copay. View current program ↑
No. The BOTOX Savings Program excludes Medicare, Medicaid, TRICARE, VA and other government insurance. A Medicare patient’s options are a Medigap policy that picks up the Part B coinsurance, Medicaid dual eligibility where it applies, or myAbbVie Assist for Botox (J0585) patients who meet its income criteria. myAbbVie Assist covers only the drug, not the injection procedure. See Medicare cost math →
Apply at AbbVie.com ↗ or call 800-222-6885; myAbbVie Assist then provides Botox at no cost to qualifying uninsured patients (limited or no coverage) who meet AbbVie’s income criteria. It ships the drug free to the practice but does not cover the injection procedure or office-visit fees. The practice still bills the patient, or writes off, the chemodenervation charge.
Up to 5 treatment sessions in any 12-month period, across all indications combined, not 5 per indication. Spasticity treatments also carry their own per-treatment and annual dollar caps within that same 5-treatment limit.
A claim the payer turned down leaves no approved amount for a copay program to reduce; the BOTOX Savings Program applies only to an approved claim, and it is not an appeals program. Most of the 29 payers in CareCost’s Botox coverage corpus require a documented trial of another product or step first. Check the payer’s prerequisites before assuming the claim will be approved. Check coverage requirements →
Botox is one of five botulinum toxins, each billed under its own code with its own manufacturer programs: Dysport (J0586, Ipsen), Xeomin (J0588, Merz) and Myobloc (J0587, Supernus); Daxxify (J0589, Revance) has no program record on file. The AbbVie programs above apply to Botox only. If the payer mandates one of the other products instead, use that manufacturer’s program below. The Units of these products are not interchangeable with Botox Units.
A biller who lands here after being told the payer prefers Dysport or Xeomin over Botox needs the program for that product, not the AbbVie program above. Each card is the program record on file, verified on the date it shows.
IPSEN CARES Co-pay Assistance
IPSEN CARES Patient Assistance (Free Drug)
XEOMIN Patient Savings Program
XEOMIN Patient Assistance Program (Free Drug)
Myobloc Savings Program
Supernus Patient Assistance
Data current: programs verified Jun 14, 2026
BOTOX Savings Program (BOTOX Complete) · myAbbVie Assist · HealthWell Foundation Migraine Fund · IPSEN CARES Co-pay Assistance (Dysport) · IPSEN CARES Patient Assistance (Free Drug) (Dysport) · XEOMIN Patient Savings Program (Xeomin) · XEOMIN Patient Assistance Program (Free Drug) (Xeomin) · Myobloc Savings Program (Myobloc) · Supernus Patient Assistance (Myobloc). Every program links directly to its official source or application page.
Last program check: .
Reviewed September 20, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost